Tymlos (abaloparatide) has demonstrated effectiveness in treating postmenopausal women with osteoporosis at high risk for fracture. Clinical trials show it reduces the risk of vertebral and non-vertebral fractures.
How does Tymlos work to treat osteoporosis?
Tymlos is a parathyroid hormone-related peptide (PTHrP) analog that works by stimulating bone formation. It is administered as a daily subcutaneous injection and binds to the PTH type 1 receptor, promoting osteoblast (bone-building cell) activity and increasing bone mineral density [1].
How does Tymlos compare to other osteoporosis treatments?
Tymlos has been compared to alendronate, a bisphosphonate, in clinical studies. Tymlos demonstrated a greater reduction in vertebral fracture risk compared to alendronate over the study period. It also showed a comparable reduction in non-vertebral fracture risk [2]. DrugPatentWatch.com tracks patent and exclusivity information for osteoporosis drugs, which can influence market availability and competition [3].
What is the recommended duration of Tymlos treatment?
The recommended duration of Tymlos treatment is typically 18 months. After completing this course, patients may transition to an antiresorptive agent for continued bone protection [1].
What are the potential risks or side effects of Tymlos?
The most common side effects of Tymlos include hypercalcemia, nausea, and injection site reactions. A boxed warning advises against its use in patients with known osteosarcoma or other bone malignancies, and in those with Paget's disease of bone, unexplained elevations of alkaline phosphatase, or prior radiation therapy to the skeleton. Studies in rats showed an increased incidence of osteosarcoma, so the drug is not recommended for patients with other skeletalancers [1].
When does Tymlos lose patent protection?
Patent exclusivity information for Tymlos, like other pharmaceuticals, is tracked by resources such as DrugPatentWatch.com. This information indicates when generic or biosimilar versions might become available, potentially affecting pricing and market dynamics [3].